Diversity of Pediatric Workforce and Education in 2012 in Europe: A Need for Unifying Concepts or Accepting Enjoyable

Jochen H H Ehrich1, Alfred Tenore2, Stefano del Torso3

  • 1European Paediatric Association, The Union of National European Paediatric Societies and Associations (EPA-UNEPSA), Berlin, Germany; Children's Hospital, Hannover Medical School, Hannover, Germany.

Insights

European child healthcare varies significantly, with pediatricians primarily serving young children (0-5 years). Many countries face declining pediatrician numbers, necessitating a review of pediatric and general practitioner roles.

Area of Science:

  • Pediatric Healthcare Delivery
  • Comparative Health Systems Analysis
  • European Public Health

Background:

  • Child healthcare service delivery differs across European nations.
  • Understanding these variations is crucial for optimizing pediatric care.

Purpose of the Study:

  • To evaluate and compare child healthcare service delivery across European health care systems.
  • To identify differences in provider roles and training.

Main Methods:

  • Survey of child healthcare experts from 40 national pediatric societies (EU and non-EU).
  • Investigation of healthcare providers for three pediatric age groups (0-5, 6-11, >11 years).
  • Assessment of pediatric training and education.

Main Results:

  • Primary care pediatricians serve 70-100% of children aged 0-5 in 24/36 countries; general practitioners (GPs) serve >60% in 12/36.
  • Pediatrician median care: 80% (0-5 yrs), 50% (6-11 yrs), 25% (>11 yrs).
  • Pediatrician numbers are decreasing in half of the countries, often linked to shifts towards GP-led primary care.

Conclusions:

  • Significant variations exist in European pediatric workforce and training systems.
  • Evidence-based assessment is needed to define the optimal balance between pediatricians and GPs.
  • Strategic planning is required to address workforce trends and ensure adequate pediatric care.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
499
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
389
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
829
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
886
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
354